Doi.org/10.1074/jbc.M116.752493

Target Article

Protein phosphatase PP5 controls bone mass and the negative effects of rosiglitazone on bone through reciprocal regulation of PPARchar(39) (peroxisome proliferator-activated receptor char(39)) and RUNX2 (runt-related transcription factor 2)  ; Lance A Stechschulte Chunxi Ge Terry D Hinds Jr Edwin R Sanchez Renny T Franceschi Beata Lecka-; NULL; 09/29/2016; https://doi.org/10.1074/jbc.M116.752493

Reasons

Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.